Larimar Therapeutics, Inc. (LRMR)
2.27
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 10:27
Larimar Therapeutics Price to Book Value : 1.860 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 1.860 |
| October 21, 2026 | 1.983 |
| October 20, 2026 | 2.000 |
| October 19, 2026 | 1.737 |
| October 16, 2026 | 1.627 |
| October 15, 2026 | 1.631 |
| October 14, 2026 | 1.713 |
| October 13, 2026 | 1.77 |
| October 12, 2026 | 2.073 |
| October 09, 2026 | 2.188 |
| October 08, 2026 | 2.212 |
| October 07, 2026 | 2.254 |
| October 06, 2026 | 2.278 |
| October 05, 2026 | 2.344 |
| October 02, 2026 | 2.426 |
| October 01, 2026 | 2.508 |
| September 30, 2026 | 2.618 |
| September 29, 2026 | 2.573 |
| September 28, 2026 | 2.598 |
| September 25, 2026 | 2.520 |
| September 24, 2026 | 2.721 |
| September 23, 2026 | 3.167 |
| September 22, 2026 | 3.130 |
| September 21, 2026 | 3.138 |
| September 18, 2026 | 3.106 |
| Date | Value |
|---|---|
| September 17, 2026 | 3.114 |
| September 16, 2026 | 3.220 |
| September 15, 2026 | 3.204 |
| September 14, 2026 | 3.098 |
| September 11, 2026 | 3.212 |
| September 10, 2026 | 3.155 |
| September 09, 2026 | 3.171 |
| September 08, 2026 | 3.339 |
| September 04, 2026 | 3.138 |
| September 03, 2026 | 3.138 |
| September 02, 2026 | 3.171 |
| September 01, 2026 | 3.229 |
| August 31, 2026 | 3.130 |
| August 28, 2026 | 3.286 |
| August 27, 2026 | 3.319 |
| August 26, 2026 | 3.417 |
| August 25, 2026 | 3.409 |
| August 24, 2026 | 3.319 |
| August 21, 2026 | 3.425 |
| August 20, 2026 | 3.409 |
| August 19, 2026 | 3.483 |
| August 18, 2026 | 3.327 |
| August 17, 2026 | 3.540 |
| August 14, 2026 | 3.573 |
| August 13, 2026 | 3.499 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.604 |
| Alnylam Pharmaceuticals, Inc. | 22.14 |
| Anika Therapeutics, Inc. | 2.056 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.887 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0424 |
| Price | 2.27 |
| Earnings Yield | -87.36% |
| Market Cap | 236.95M |
| PEGY Ratio | -0.0424 |